Wilms’ tumor gene 1 expression: an independent acute leukemia prognostic indicator following allogeneic hematopoietic SCT

Monitoring of minimal residual disease by quantitative WT1 gene expression following reduced intensity conditioning allogeneic stem cell transplantation in acute myeloid leukemia

(2010) Anna Candoni et al.   CLINICAL TRANSPLANTATION

Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia

(2010) G. Gianfaldoni et al.   HAEMATOLOGICA

Wilms’ tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome

(2009) Antonia Busse et al.   ANNALS OF HEMATOLOGY

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

(2009) H. Dohner et al.   BLOOD

HighWT1gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event-free survival

(2009) David A. Jacobsohn et al.   BRITISH JOURNAL OF HAEMATOLOGY

WT1 monitoring in core binding factor AML: Comparison with specific chimeric products

(2009) Adriana Lasa et al.   LEUKEMIA RESEARCH

Wilms tumour gene 1 overexpression in bone marrow as a marker for minimal residual disease in acute myeloid leukaemia

(2008) Mauri M. Hämäläinen et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Quantitative assessment ofWT1gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia

(2008) Anna Candoni et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Modified Donor Lymphocyte Infusion after HLA-Mismatched/Haploidentical T Cell-replete Hematopoietic Stem Cell Transplantation for Prophylaxis of Relapse of Leukemia in Patients with Advanced Leukemia

(2008) Xiao-Jun Huang et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease

(2008) YaZhen Qin et al.   LEUKEMIA RESEARCH

Different kinetic patterns of BCR-ABL transcript levels in imatinib-treated chronic myeloid leukemia patients after achieving complete cytogenetic response

(2007) Y. Z. QIN et al.   International Journal of Laboratory Hematology